# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-17-000130
Filing Date
2017-04-10
Accepted
2017-04-10 16:41:19
Documents
8
Effectiveness Date
2017-04-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | MERCK & CO. INC. - DEFA14A | lmrk2017_defa14a.htm | DEFA14A | 27031
2 | GRAPHIC | lmrk_proxy4.jpg | GRAPHIC | 14807
3 | GRAPHIC | lmrk_proxy3.jpg | GRAPHIC | 188726
4 | GRAPHIC | lmrk_proxy2.jpg | GRAPHIC | 279873
5 | GRAPHIC | lmrk_proxy1.jpg | GRAPHIC | 226362
6 | GRAPHIC | lmrkx1x1.jpg | GRAPHIC | 14630
7 | GRAPHIC | check.jpg | GRAPHIC | 882
8 | GRAPHIC | uncheck.jpg | GRAPHIC | 8006
| Complete submission text file | 0001308179-17-000130.txt |  | 1038987

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-06571 | Film No.: 17753888
SIC: 2834 Pharmaceutical Preparations